BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 16388725)

  • 1. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
    Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A; Seeber A
    Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.
    Chen X; Yang M; Cheng Y; Liu GJ; Zhang M
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009481. PubMed ID: 24151011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis.
    Aggarwal P; Aggarwal K; Jain VK
    J Dermatolog Treat; 2016 Nov; 27(6):546-551. PubMed ID: 27052200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
    Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
    J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
    El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque-type psoriasis.
    Ozkan I; Köse O; Ozmen I; Arca E
    Int J Dermatol; 2012 May; 51(5):609-13. PubMed ID: 22515588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
    Prignano F; Buggiani G; Lotti T
    Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
    J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of UV-based therapy for psoriasis.
    Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
    Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis.
    Dua I; Aggarwal K; Jain VK
    Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
    Coimbra S; Oliveira H; Belo L; Figueiredo A; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.